Perspective Therapeutics (CATX) Total Current Liabilities (2011 - 2026)

Perspective Therapeutics (CATX) has 16 years of Total Current Liabilities data on file, last reported at $31.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 148.33% year-over-year to $31.5 million; the trailing twelve-month figure through Mar 2026 stood at $31.5 million (up 148.33% YoY), and the FY2025 full-year result was $28.7 million, up 57.32% from the prior year.
• Total Current Liabilities climbed to $31.5 million in Q1 2026, from $28.7 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $31.5 million in Q1 2026 to a low of $2.0 million in Q1 2022.
• A 5-year average of $13.5 million and a median of $12.7 million in 2025 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities soared 402.37% in 2023 and fell 26.74% in 2025, its largest moves.
• Tracing CATX's Total Current Liabilities over 5 years: stood at $3.1 million in 2022, then soared by 402.37% to $15.7 million in 2023, then increased by 16.38% to $18.2 million in 2024, then jumped by 57.32% to $28.7 million in 2025, then rose by 9.79% to $31.5 million in 2026.
• Business Quant data shows CATX's Total Current Liabilities at $31.5 million in Q1 2026, $28.7 million in Q4 2025, and $20.6 million in Q3 2025.